Anthony G. Quinn - Dec 31, 2021 Form 5 Insider Report for Aeglea BioTherapeutics, Inc. (AGLE)

Role
President & CEO, Director
Signature
/s/ James Kastenmayer, by power of attorney
Stock symbol
AGLE
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/14/2022, 04:19 PM
Previous filing
Dec 13, 2021
Next filing
Feb 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGLE Common Stock Gift $0 -57.5K -14.87% $0.00 329K Dec 28, 2018 Direct
transaction AGLE Common Stock Gift $0 +57.5K $0.00 57.5K Dec 28, 2018 See footnote F1
transaction AGLE Common Stock Gift $0 -175K -34.74% $0.00 329K Oct 14, 2021 Direct
transaction AGLE Common Stock Gift $0 +175K +517.72% $0.00 209K Oct 14, 2021 See footnote F2
transaction AGLE Common Stock Gift $0 -23.8K -6.75% $0.00 329K Oct 18, 2021 Direct
transaction AGLE Common Stock Gift $0 +23.8K +12.87% $0.00 209K Oct 18, 2021 See footnote F2
transaction AGLE Common Stock Gift $0 -10K -2.95% $0.00 329K Oct 20, 2021 Direct
transaction AGLE Common Stock Gift $0 +10K +5.03% $0.00 209K Oct 20, 2021 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by the Anthony G. Quinn Irrevocable Trust of 2018, of which the Reporting Person's spouse is trustee.
F2 These securities are held by the Quinn Family Irrevocable Trust of 2021, of which the Reporting Person's spouse is trustee.